182 related articles for article (PubMed ID: 17065685)
1. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.
Simó R; Lecube A; Genescà J; Esteban JI; Hernández C
Diabetes Care; 2006 Nov; 29(11):2462-6. PubMed ID: 17065685
[TBL] [Abstract][Full Text] [Related]
2. Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
Lecube A; Hernández C; Simó R; Esteban JI; Genescà J
Am J Gastroenterol; 2007 Oct; 102(10):2189-95. PubMed ID: 17617205
[TBL] [Abstract][Full Text] [Related]
3. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
4. Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.
Romero-Gómez M; Fernández-Rodríguez CM; Andrade RJ; Diago M; Alonso S; Planas R; Solá R; Pons JA; Salmerón J; Barcena R; Perez R; Carmona I; Durán S
J Hepatol; 2008 May; 48(5):721-7. PubMed ID: 18308416
[TBL] [Abstract][Full Text] [Related]
5. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
6. Association of diabetes mellitus and chronic hepatitis C virus infection.
Mason AL; Lau JY; Hoang N; Qian K; Alexander GJ; Xu L; Guo L; Jacob S; Regenstein FG; Zimmerman R; Everhart JE; Wasserfall C; Maclaren NK; Perrillo RP
Hepatology; 1999 Feb; 29(2):328-33. PubMed ID: 9918906
[TBL] [Abstract][Full Text] [Related]
7. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
8. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
12. [Investigation on the incidence of diabetes in chronic hepatitis C patients and their HCV genotypes].
Zhao P; Wang JB; Jiao J
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):86-8. PubMed ID: 16494773
[TBL] [Abstract][Full Text] [Related]
13. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study.
Kawaguchi T; Nagao Y; Tanaka K; Ide T; Harada M; Kumashiro R; Sata M
Int J Mol Med; 2005 Jul; 16(1):109-14. PubMed ID: 15942686
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
Huang JF; Yu ML; Dai CY; Hsieh MY; Hwang SJ; Hsiao PJ; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL
Am J Gastroenterol; 2008 Aug; 103(8):1933-40. PubMed ID: 18637090
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
Arao M; Murase K; Kusakabe A; Yoshioka K; Fukuzawa Y; Ishikawa T; Tagaya T; Yamanouchi K; Ichimiya H; Sameshima Y; Kakumu S
J Gastroenterol; 2003; 38(4):355-60. PubMed ID: 12743775
[TBL] [Abstract][Full Text] [Related]
19. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.
Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Hirakawa M; Ikeda K; Kumada H
Hepatology; 2009 Mar; 49(3):739-44. PubMed ID: 19127513
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and incident type 2 diabetes.
Mehta SH; Brancati FL; Strathdee SA; Pankow JS; Netski D; Coresh J; Szklo M; Thomas DL
Hepatology; 2003 Jul; 38(1):50-6. PubMed ID: 12829986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
